文献速递消化道肿瘤放疗放疗物理与技术

剂量平均线性能量传递对胰腺癌碳离子放疗肿瘤控制的影响

Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2019-11-27

该回顾性研究分析2013年接受根治性碳离子放疗同步化疗的18例原发性胰腺癌患者,照射剂量55.2 Gy(RBE),评估剂量平均LET与局部控制的关系。中位随访22个月,18个月局部控制率和总生存率分别为62.5%和70.1%,未观察到≥3级晚期毒性。GTV内最小剂量平均LET较高(≥44 keV/μm)的患者局部控制显著更优(18个月局部控制率100.0% vs 34.3%,p=0.0366)。

要点

  • GTV内最小剂量平均LET≥44 keV/μm与更好的局部控制相关。
  • 18个月局部控制率和总生存率分别为62.5%和70.1%。
  • 4例(22%)出现局部复发,均为野内中心性复发。

核心结论

  • GTV内最小剂量平均LET与原发性胰腺癌局部控制显著相关。
  • 调节GTV内剂量平均LET可能改善不可切除原发性胰腺癌碳离子放疗的疗效。

研究设计与样本

  • 回顾性分析2013年接受根治性碳离子放疗同步化疗的18例原发性胰腺癌患者。
  • 照射剂量为55.2 Gy(RBE),评估剂量平均LET与局部控制的关系。

主要发现

  • 所有患者均为组织学确诊的腺癌,中位随访22个月。
  • 18个月局部控制率和总生存率分别为62.5%和70.1%。
  • 未观察到≥3级晚期毒性。
  • 4例(22%)出现局部复发,均为野内中心性复发。
  • GTV剂量覆盖无显著差异,但GTV内最小剂量平均LET较高者局部控制更好(≥44 keV/μm;18个月局部控制率100.0% vs 34.3%;p=0.0366)。

关键数值与推荐

  • GTV内最小剂量平均LET≥44 keV/μm者18个月局部控制率为100.0%,<44 keV/μm者为34.3%(p=0.0366)。

临床怎么用

  • 碳离子放疗计划设计时可考虑将GTV内最小剂量平均LET作为优化参数。
  • 对不可切除原发性胰腺癌,在保证剂量覆盖的同时关注LET分布可能改善局部控制。

局限性

  • 回顾性分析,样本量仅18例。
  • 中位随访22个月,随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: High linear energy transfer (LET) radiation carbon-ion radiotherapy (C-ion RT) is one of the most promising modalities for treating unresectable primary pancreatic cancers. However, how LET contributes to a therapeutic effect is not clear. To assess whether there is an enhanced effect of high LET radiation on tumour control, we aimed to determine the impact of dose-averaged LET on local control (LC) of primary pancreatic tumours. MATERIALS AND METHODS: A retrospective analysis of 18 patients with primary pancreatic carcinomas treated with definitive C-ion RT with concurrent chemotherapy in 2013 was conducted. The dose of irradiation was 55.2 Gy (RBE). The relationship between dose-averaged LET and LC of primary tumours was evaluated. RESULTS: All patients had histologically confirmed adenocarcinoma. The median follow-up duration was 22 months. The actuarial LC and overall survival (OS) at 18 months were 62.5% and 70.1%, respectively. There were no cases of grade ≥3 late toxicities observed. Local recurrences developed in four patients (22%), all of which were infield central recurrences. Although there were no significant differences in gross tumour volume (GTV) dose coverage, patients with higher minimum dose-averaged LET (LETmin) values within the GTV had better LC (dose-averaged LETmin ≥44 keV/microm; 18-months LC 100.0% vs 34.3%; p = 0.0366). CONCLUSION: Dose-averaged LETmin within the GTV was significantly associated with LC of primary pancreatic cancers. Our data suggest that outcomes for patients with unresectable primary pancreatic cancers receiving C-ion RT can be improved by modulating the dose-averaged LET within the GTV.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Hagiwara Y, Bhattacharyya T, Matsufuji N, et al. Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer. Clin Transl Radiat Oncol. 2019. PMID: 31886424. doi:10.1016/j.ctro.2019.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。